Show simple item record

dc.contributor.authorÇAVUŞOĞLU, Aysel
dc.contributor.authorBEBEK, Nerses
dc.contributor.authorÖZER, ARİF
dc.contributor.authorInan, Gorkem Sirin
dc.contributor.authorBAYKAL, Betül
dc.contributor.authorYeni, Kubra
dc.contributor.authorTÜLEK, Zeliha
dc.date.accessioned2023-02-21T08:08:19Z
dc.date.available2023-02-21T08:08:19Z
dc.date.issued2022
dc.identifier.citationYeni K., TÜLEK Z., ÖZER A., ÇAVUŞOĞLU A., Inan G. S., BAYKAL B., BEBEK N., "The effect of fear of COVID-19 on quality of life in patients with epilepsy", Neurology Asia, cilt.27, sa.1, ss.109-116, 2022
dc.identifier.issn1823-6138
dc.identifier.othervv_1032021
dc.identifier.otherav_149187e9-36a6-4a42-b9b1-5c475eb33191
dc.identifier.urihttp://hdl.handle.net/20.500.12627/186400
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85130034719&origin=inward
dc.identifier.urihttps://doi.org/10.54029/2022jzi
dc.description.abstract© 2022, ASEAN Neurological Association. All rights reserved.Objective: In the COVID-19 pandemic period, the effect of COVID-19 fear on quality of life was uncertain. This present study examined the effect of fear of COVID-19 on quality of life in patients with epilepsy through anxiety and depression. Methods: This single-center, cross-sectional study was conducted with a total of 319 adult patients with epilepsy. The mean age of the patients was 36.0 (± 11.1) years, and 53% were male. The mean duration of diagnosis was 16.0 (± 10.6) years, and more than half of the patients (52.4%) were using two and more antiepileptic drugs. Data were collected online between 15 December 2020 and 5 January 2021. COVID-19 Fear Scale, Beck Depression Inventory, Worry and Anxiety Questionnaire, and Epilepsy Quality of Life Scale-10 were used for data collection. Serial mediation analysis was conducted to determine the effect of COVID-19 fear on quality of life. Results: Although there was a significant correlation between them, the fear of COVID-19 did not directly affect the quality of life. The fear of COVID-19 increased anxiety and depression respectively, the increase in the mediators also decreased the quality of life. Conclusion: The fear of COVID-19 experienced by patients with epilepsy did not have a significant direct effect on the quality of life. However, it was found that it had an indirect effect on the quality of life by increasing mental health problems such as anxiety and depression, the indirect effect was mostly on anxiety.
dc.language.isoeng
dc.subjectYaşam Bilimleri
dc.subjectNöroloji (klinik)
dc.subjectSağlık Bilimleri
dc.subjectNöroloji
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKLİNİK NÖROLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.titleThe effect of fear of COVID-19 on quality of life in patients with epilepsy
dc.typeMakale
dc.relation.journalNeurology Asia
dc.contributor.departmentİstanbul Üniversitesi , Sağlık Bilimleri Enstitüsü , Hemşirelik Fakültesi Bölümü
dc.identifier.volume27
dc.identifier.issue1
dc.identifier.startpage109
dc.identifier.endpage116
dc.contributor.firstauthorID4204033


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record